![PRD_001161 PRD_001161](https://data.pdbj.org/pdbjplus/data/cc/svg/EC6.svg) | PRD_001161 | Name: | N-hexanoyl-L-valyl-N~1~-[(4S,5S,6R)-5-hydroxy-2,6-dimethyloctan-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C28 H54 N4 O5 | Description: | Originated from (S)-N1-((S,Z)-2,6-dimethyl-5-oxooct-6-en-4-yl)-2-((S)-2-hexanamido-3-methylbutanamido)-N5,N5-dimethylpentanediamide that reacts with N-terminal Thr of the protein, opening double bonds of the original compound and making two covalent linkages with the amino group and side chain hydroxyl of the Thr. The PRD represents the bound form. | Definition date: | 2014-07-02 | Last modified: | 2017-09-14 |
|
![PRD_001163 PRD_001163](https://data.pdbj.org/pdbjplus/data/cc/svg/29D.svg) | PRD_001163 | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | Formula: | C34 H40 N10 O15 | Definition date: | 2014-06-18 | Last modified: | 2017-09-14 |
|
![PRD_001164 PRD_001164](https://data.pdbj.org/pdbjplus/data/cc/svg/29C.svg) | PRD_001164 | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | Formula: | C29 H33 N9 O12 | Definition date: | 2014-06-18 | Last modified: | 2017-09-14 |
|
![PRD_001165 PRD_001165](https://data.pdbj.org/pdbjplus/data/cc/svg/28Z.svg) | PRD_001165 | Name: | N-(4-{[(2-amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-gamma-glutamyl-L-glutamic acid | Formula: | C24 H26 N8 O9 | Definition date: | 2014-06-18 | Last modified: | 2017-09-14 |
|
![PRD_001174 PRD_001174](https://data.pdbj.org/pdbjplus/data/cc/svg/KVI.svg) | PRD_001174 | Name: | (2S)-2-{[(2R,5S)-5-{[(2S,3S)-2-{[(2S,3R)-2-(acetylamino)-3-hydroxybutanoyl]amino}-3-methylpentanoyl]amino}-2-butyl-4-oxononanoyl]amino}-N~1~-[(2S)-1-amino-5-carbamimidamido-1-oxopentan-2-yl]pentanediamide | Formula: | C36 H66 N10 O9 | Definition date: | 2013-10-16 | Last modified: | 2017-09-14 |
|
![PRD_001175 PRD_001175](https://data.pdbj.org/pdbjplus/data/cc/svg/2G7.svg) | PRD_001175 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isobutylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | Formula: | C19 H32 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
![PRD_001177 PRD_001177](https://data.pdbj.org/pdbjplus/data/cc/svg/2GC.svg) | PRD_001177 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(phenethylamino)pentan-2-yl)phosphonamidic acid | Formula: | C23 H32 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
![PRD_001178 PRD_001178](https://data.pdbj.org/pdbjplus/data/cc/svg/2G8.svg) | PRD_001178 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-oxo-1-(propylamino)pentan-2-yl)phosphonamidic acid | Formula: | C18 H30 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
![PRD_001179 PRD_001179](https://data.pdbj.org/pdbjplus/data/cc/svg/2G9.svg) | PRD_001179 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(((S)-2-methylbutyl)amino)-1-oxopentan- 2-yl)phosphonamidic
acid | Formula: | C20 H34 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
![PRD_001180 PRD_001180](https://data.pdbj.org/pdbjplus/data/cc/svg/2G6.svg) | PRD_001180 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-((3,3-dimethylbutyl)amino)-4-methyl-1-oxopentan-2-yl)phosphonamidic
acid | Formula: | C21 H36 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
![PRD_001182 PRD_001182](https://data.pdbj.org/pdbjplus/data/cc/svg/2GZ.svg) | PRD_001182 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-4-methyl-1-(neopentylamino)-1-oxopentan-2-yl)phosphonamidic acid | Formula: | C20 H34 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
![PRD_001183 PRD_001183](https://data.pdbj.org/pdbjplus/data/cc/svg/2H0.svg) | PRD_001183 | Name: | P-((((benzyloxy)carbonyl)amino)methyl)-N-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)phosphonamidic acid | Formula: | C20 H34 N3 O5 P | Definition date: | 2014-04-02 | Last modified: | 2017-09-14 |
|
![PRD_001200 PRD_001200](https://data.pdbj.org/pdbjplus/data/cc/svg/2LR.svg) | PRD_001200 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(1R,2S)-1-hydroxy-4-methyl-1-[(2R)-2-methyloxiran-2-yl]pentan-2-yl}-L-leucinamide | Formula: | C29 H47 N3 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
![PRD_001205 PRD_001205](https://data.pdbj.org/pdbjplus/data/cc/svg/2LV.svg) | PRD_001205 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S,3S)-2-hydroxy-5-methyl-1-oxo-1-(phenylamino)hexan-3-yl]-L-leucinamide | Formula: | C33 H48 N4 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
![PRD_001206 PRD_001206](https://data.pdbj.org/pdbjplus/data/cc/svg/2M1.svg) | PRD_001206 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(3S)-5-methyl-1-(methylsulfonyl)hexan-3-yl]-L-leucinamide | Formula: | C28 H47 N3 O6 S | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
![PRD_001207 PRD_001207](https://data.pdbj.org/pdbjplus/data/cc/svg/2MK.svg) | PRD_001207 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2R,3S)-1,2-dihydroxy-5-methylhexan-3-yl]-L-leucinamide | Formula: | C27 H45 N3 O6 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
![PRD_001210 PRD_001210](https://data.pdbj.org/pdbjplus/data/cc/svg/ALD.svg) | PRD_001210 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-[(2S)-1-hydroxy-4-methylpentan-2-yl]-L-leucinamide | Formula: | C26 H43 N3 O5 | Definition date: | 2014-02-12 | Last modified: | 2017-09-14 |
|
![PRD_001217 PRD_001217](https://data.pdbj.org/pdbjplus/data/cc/svg/2OY.svg) | PRD_001217 | Name: | N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-4-methylbenzenesulfonamide (Bound Form) | Formula: | C14 H23 Cl N2 O3 S | Definition date: | 2014-04-23 | Last modified: | 2017-09-14 |
|
![PRD_001230 PRD_001230](https://data.pdbj.org/pdbjplus/data/cc/svg/2YS.svg) | PRD_001230 | Name: | D-valyl-N-[(2S,3S)-7-amino-1-chloro-2-hydroxyheptan-3-yl]-L-leucinamide | Formula: | C18 H37 Cl N4 O3 | Definition date: | 2014-09-03 | Last modified: | 2017-09-14 |
|
![PRD_001231 PRD_001231](https://data.pdbj.org/pdbjplus/data/cc/svg/2YT.svg) | PRD_001231 | Name: | L-phenylalanyl-N-[(2S,3S)-6-carbamimidamido-1-chloro-2-hydroxyhexan-3-yl]-L-phenylalaninamide | Formula: | C25 H35 Cl N6 O3 | Definition date: | 2014-09-03 | Last modified: | 2017-09-14 |
|
![PRD_001244 PRD_001244](https://data.pdbj.org/pdbjplus/data/cc/svg/3E5.svg) | PRD_001244 | Name: | N-[(benzyloxy)carbonyl]-L-leucyl-N-{(2S,3S)-1-[(2,4-dimethylphenyl)amino]-2-hydroxy-5-methyl-1-oxohexan-3-yl}-L-leucinamide | Formula: | C35 H52 N4 O6 | Definition date: | 2014-08-13 | Last modified: | 2017-09-14 |
|
![PRD_001258 PRD_001258](https://data.pdbj.org/pdbjplus/data/cc/svg/39S.svg) | PRD_001258 | Name: | N-[4-({[(6S)-2-amino-4-oxo-3,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-gamma-glutamyl-L-gamma-glutamyl-L-glutamic acid | Formula: | C29 H37 N9 O12 | Definition date: | 2015-01-14 | Last modified: | 2017-09-14 |
|
![PRD_002274 PRD_002274](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002274.svg) | PRD_002274 | Name: | N-[(6aR,12R,15aR,17R,21R,23aR)-17,21-dimethyl-6,11,15,20,23-pentaoxooctadecahydro-2H,6H,11H,15H-pyrido[2,1-i]dipyrrolo[2,1-c:2',1'-l][1,4,7,10,13]oxatetraazacyclohexadecin-12-yl]-Nalpha-[(2E)-pent-2-enoyl]-L-phenylalaninamide | Formula: | C37 H50 N6 O8 | Definition date: | 2017-06-21 | Last modified: | 2017-06-21 |
|
![PRD_002261 PRD_002261](https://data.pdbj.org/pdbjplus/data/prd/svg/PRD_002261.svg) | PRD_002261 | Formula: | C92 H138 N27 O24 S | Description: | single helix from the B-domain of protein A bound to IgG1 Fc | Definition date: | 2017-05-24 | Last modified: | 2017-05-24 |
|
![PRD_000902 PRD_000902](https://data.pdbj.org/pdbjplus/data/cc/svg/ONK.svg) | PRD_000902 | Name: | N-hexanoyl-L-valyl-N~1~-[(3S,4S)-3-hydroxy-2,6-dimethylhept-1-en-4-yl]-N~5~,N~5~-dimethyl-L-glutamamide | Formula: | C27 H50 N4 O5 | Description: | vinylketone carmaphycin analogue VNK1, single bound form | Definition date: | 2014-01-29 | Last modified: | 2017-05-04 |
|